GRAFF FOR NATION: REVIVING MASTERPIECES WITH GRAFFITI ART IN LANGKAWI
LANGKAWI, Malaysia, Oct. 23, 2024 /PRNewswire/ — The Ministry of Tourism, Arts, and Culture (MOTAC), through its agency, the National Art Gallery Malaysia, is proud to announce the upcoming ‘Graff for Nation’ event, taking place from 25th to 29th October 2024, at the Kuah Old Hospi
DAISO NEW STORE OPENING IN VACAVILLE, CALIFORNIA
VACAVILLE, Calif., Oct. 23, 2024 /PRNewswire/ — Daiso, the renowned global retail chain offering a wide range of affordable and unique products, is thrilled to announce the grand opening at Nut Tree in Vacaville, California on November 2nd. “We are thrilled to open our store at Nut Tree
DAISO NEW STORE OPENING IN SAN ANTONIO, TEXAS
SAN ANTONIO, Oct. 23, 2024 /PRNewswire/ — Daiso, the renowned global retail chain offering a wide range of affordable and unique products, is thrilled to announce the grand opening at Westover Marketplace in San Antonio, Texas on November 2nd. “We are thrilled to open our store at Westo
EISAI TO PRESENT UPDATED DUAL-ACTING LECANEMAB DATA, RESEARCH ON BLOOD BIOMARKERS FOR PREDICTING PRESENCE OF AMYLOID IN THE BRAIN AND NEW FINDINGS ON THE ANTI-MTBR (MICROTUBULE BINDING REGION) TAU ANTIBODY E2814 AT THE 17TH CLINICAL TRIALS FOR ALZHEIMER’S DISEASE CONFERENCE (CTAD)
TOKYO, Oct. 23, 2024 /PRNewswire/ — Eisai Co. Ltd (Headquarters: Tokyo, CEO: Haruo Naito, “Eisai”) announced today that the company will present the latest findings on its Alzheimer’s disease (AD) pipeline and research, including our dual-acting, anti-amyloid beta (Aβ) proto
PL Developments Announces Early Tender Time Results for the Previously Announced Exchange Offer
WESTBURY, N.Y., Oct. 23, 2024 /PRNewswire/ — P & L Development Holdings, LLC (“PLD” or the “Company”) today announced the early participation results of certain of its subsidiaries’ previously announced offer to exchange (the “Exchange Offer”) up t
ESET Opens New North America Headquarters in San Diego
State-of-the-Art Building Emphasizes Employee Experience and Sustainability SAN DIEGO, Oct. 23, 2024 /PRNewswire/ — ESET, a global leader in cybersecurity, today announced the opening of its new North America headquarters in Downtown San Diego. Representing a significant milestone in the com
Get Your Paws on Meiji Hello Panda™ Pretzel
YORK, Pa., Oct. 23, 2024 /PRNewswire/ — Meiji Hello Panda™ Pretzel, a twist on the beloved Meiji Hello Panda cookies produced by Meiji America Inc., is launching at select retailers nationwide. This bite sized snack brings playful energy Meiji Hello Panda lovers will recognize, with a taste
GRAIL Presents Initial Results From REFLECTION Real-World Evidence Study of Galleri® Multi-Cancer Early Detection (MCED) Test at the Early Detection of Cancer Conference
Study Participants from Veteran Affairs Sites Include a Diverse Population With Toxic Exposure MENLO PARK, Calif., Oct. 23, 2024 /PRNewswire/ — GRAIL, Inc. (Nasdaq: GRAL), a healthcare company whose mission is to detect cancer early when it can be cured, today announced early results from t
Muon Space Selected by Space Development Agency for HALO Program
MOUNTAIN VIEW, Calif. , Oct. 23, 2024 /PRNewswire/ — Muon Space, an end-to-end Space Systems Provider that designs, builds, and operates mission-tailored low-earth orbit (LEO) satellite constellations, today announced its selection by the Space Development Agency (SDA) for the Hybrid Acquisi
FDA Accepts New Drug Application and Grants Priority Review for TLX101-CDx (Pixclara®) Brain Cancer Imaging Agent
MELBOURNE, Australia, Oct. 24, 2024 /PRNewswire/ — Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces that the United States (U.S.) Food and Drug Administration (FDA) has accepted the New Drug Application (NDA) for TLX101-CDx (Pixclara®[1]), an agent for the imaging
